STOCK TITAN

XOMA Royalty Declares Quarterly Preferred Stock Dividends

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends

XOMA Royalty (Nasdaq: XOMA) has announced quarterly cash dividends for its Series A and Series B Cumulative Preferred Stock. Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) will receive $0.53906 per share. Holders of depositary shares for the 8.375% Series B Cumulative Perpetual Preferred Stock (Nasdaq: XOMAO) will receive $0.52344 per depositary share. The dividends will be paid on or about October 15, 2024, to holders of record as of the close of business on October 3, 2024. This announcement demonstrates XOMA's commitment to providing returns to its preferred stockholders.

XOMA Royalty (Nasdaq: XOMA) ha annunciato i dividendi in contanti trimestrali per le sue azioni privilegiate cumulative di Serie A e Serie B. Gli azionisti delle azioni privilegiate cumulative perpetue di Serie A all'8,625% (Nasdaq: XOMAP) riceveranno $0.53906 per azione. Gli azionisti delle azioni di deposito per le azioni privilegiate cumulative perpetue di Serie B all'8,375% (Nasdaq: XOMAO) riceveranno $0.52344 per azione di deposito. I dividendi saranno pagati circa il 15 ottobre 2024, agli azionisti registrati alla chiusura delle attività del 3 ottobre 2024. Questo annuncio dimostra l'impegno di XOMA a fornire ritorni ai suoi azionisti privilegiati.

XOMA Royalty (Nasdaq: XOMA) ha anunciado dividendos en efectivo trimestrales para sus acciones preferentes acumulativas de Series A y B. Los tenedores de las acciones preferentes acumulativas perpetuas de la Serie A al 8.625% (Nasdaq: XOMAP) recibirán $0.53906 por acción. Los tenedores de acciones de depósito para las acciones preferentes acumulativas perpetuas de la Serie B al 8.375% (Nasdaq: XOMAO) recibirán $0.52344 por acción de depósito. Los dividendos se pagarán aproximadamente el 15 de octubre de 2024, a los tenedores registrados al cierre de operaciones del 3 de octubre de 2024. Este anuncio demuestra el compromiso de XOMA de proporcionar retornos a sus accionistas preferentes.

XOMA 로열티(Nasdaq: XOMA)가 Series A 및 Series B 누적 우선주에 대한 분기 배당금을 발표했습니다. 8.625% Series A 누적 영구 우선주(Nasdaq: XOMAP) 보유자는 주당 $0.53906을 받게 됩니다. 8.375% Series B 누적 영구 우선주(Nasdaq: XOMAO)의 예탁주식 보유자는 예탁주식당 $0.52344을 받게 됩니다. 이 배당금은 2024년 10월 15일 경에 지급될 예정이며, 2024년 10월 3일 영업 종료 시점에 기록된 보유자에게 지급됩니다. 이 발표는 XOMA가 우선주 보유자에게 수익을 제공하겠다는 의지를 나타냅니다.

XOMA Royalty (Nasdaq: XOMA) a annoncé des dividendes en espèces trimestriels pour ses actions privilégiées cumulatives de Série A et de Série B. Les détenteurs des actions privilégiées cumulatives perpétuelles de Série A à 8,625 % (Nasdaq: XOMAP) recevront 0,53906 $ par action. Les détenteurs des actions de dépôt pour les actions privilégiées cumulatives perpétuelles de Série B à 8,375 % (Nasdaq: XOMAO) recevront 0,52344 $ par action de dépôt. Les dividendes seront versés aux alentours du 15 octobre 2024, aux actionnaires inscrits à la clôture des affaires le 3 octobre 2024. Cette annonce démontre l'engagement de XOMA à fournir des rendements à ses actionnaires privilégiés.

XOMA Royalty (Nasdaq: XOMA) hat vierteljährliche Bargelddividenden für seine Serie A und Serie B kumulierten Vorzugsaktien angekündigt. Die Inhaber der 8,625% Serie A kumulierten ewigen Vorzugsaktien (Nasdaq: XOMAP) erhalten $0.53906 pro Aktie. Die Inhaber der Depotanteile für die 8,375% Serie B kumulierten ewigen Vorzugsaktien (Nasdaq: XOMAO) erhalten $0.52344 pro Depotanteil. Die Dividenden werden etwa am 15. Oktober 2024 an die registrierten Inhaber zum Geschäftsschluss am 3. Oktober 2024 ausgezahlt. Diese Ankündigung zeigt XOMAs Engagement, seinen Vorzugsaktionären Renditen zu bieten.

Positive
  • Consistent dividend payments for preferred stockholders
  • Timely announcement of dividend details
  • Maintenance of dividend rates for both Series A and Series B preferred stocks
Negative
  • None.

 EMERYVILLE, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA’s Series A and Series B Cumulative Preferred Stock:

Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to $0.53906 per share.  

Holders of depositary shares, each representing 1/1000 of a share of XOMA’s 8.375% Series B Cumulative Perpetual Preferred Stock (Nasdaq: XOMAO), shall receive a cash dividend equal to $0.52344 per depositary share.  

The preferred dividends will be paid on or about October 15, 2024, to respective holders of record at the close of business on October 3, 2024.  

About XOMA Royalty Corporation
XOMA Royalty is a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health.  XOMA Royalty acquires the potential future economics associated with pre-commercial therapeutic candidates and commercial assets that have been licensed to pharmaceutical or biotechnology companies.  When XOMA Royalty acquires the future economics, the seller receives non-dilutive, non-recourse funding they can use to advance their internal drug candidate(s) or for general corporate purposes.  The Company has an extensive and growing portfolio with more than 70 assets (asset defined as the right to receive potential future economics associated with the advancement of an underlying therapeutic candidate).  For more information about the Company and its portfolio, please visit www.xoma.com or follow XOMA Royalty Corporation on LinkedIn.  

EXPLANATORY NOTE: Any references to “portfolio” in this press release refer strictly to milestone and/or royalty rights associated with a basket of drug products in development.  Any references to “assets” in this press release refer strictly to milestone and/or royalty rights associated with individual drug products in development.  

As of the date of this press release, the commercial assets in XOMA Royalty’s milestone and royalty portfolio are VABYSMO® (faricimab-svoa), OJEMDA™ (tovorafenib), MIPLYFFA™ (arimoclomol), XACIATO™ (clindamycin phosphate) vaginal gel 2%, IXINITY® [coagulation factor IX (recombinant)], and DSUVIA® (sufentanil sublingual tablet).  All other assets in the milestone and royalty portfolio are investigational compounds.  Efficacy and safety have not been established.  There is no guarantee that any of the investigational compounds will become commercially available.

Investor Contact
Juliane Snowden
XOMA Royalty Corporation
+1 646-438-9754
juliane.snowden@xoma.com
Media Contact
Kathy Vincent
KV Consulting & Management
+1 310-403-8951
kathy@kathyvincent.com

FAQ

What is the dividend amount for XOMA's Series A Preferred Stock (XOMAP)?

The dividend for XOMA's 8.625% Series A Cumulative Perpetual Preferred Stock (XOMAP) is $0.53906 per share.

What is the dividend amount for XOMA's Series B Preferred Stock (XOMAO)?

The dividend for XOMA's 8.375% Series B Cumulative Perpetual Preferred Stock (XOMAO) is $0.52344 per depositary share.

When will XOMA pay the preferred stock dividends announced on September 23, 2024?

XOMA will pay the preferred stock dividends on or about October 15, 2024.

What is the record date for XOMA's preferred stock dividends announced in September 2024?

The record date for XOMA's preferred stock dividends is October 3, 2024, at the close of business.

XOMA Royalty Corporation

NASDAQ:XOMA

XOMA Rankings

XOMA Latest News

XOMA Stock Data

353.72M
11.68M
0.84%
65.62%
1.48%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
EMERYVILLE